Immunoscore as a parameter predicting time to recurrence and disease-free survival in T4N0 stage II colon cancer patients.

Jérôme Galon,Fabienne Hermitte,Bernhard Mlecnik,Alessandro Lugli,Carlo Bifulco,Iris D. Nagtegaal,Arndt Hartmann,F. Marliot,Marc Van den Eynde,Michael H.A. Roehrl,Pamela S. Ohashi,Eva Zavadova,Toshihiko Torigoe,P. Patel,Yili Wang,Yutaka Kawakami,Francesco M. Marincola,Paolo A. Ascierto,Bernard A. Fox,Franck Pagès

Immunoscore as a parameter predicting time to recurrence and disease-free survival in T4N0 stage II colon cancer patients.

2020

4105Background: Risk assessment is particularly important to decide when to propose an adjuvant treatment for Stage II Colon Cancer (CC) patients. However, the current tumor risk features are imper...

Keywords:

Oncology
disease free survival
Stage ii colon cancer
time to recurrence
Internal medicine
Pathology
Medicine
Risk assessment
Adjuvant

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations